US Stock MarketDetailed Quotes

MCRB Seres Therapeutics

Watchlist
  • 0.825
  • +0.082+11.08%
Close Apr 26 16:00 ET
  • 0.837
  • +0.012+1.43%
Post 19:49 ET
124.58MMarket Cap-926P/E (TTM)

Seres Therapeutics Key Stats

Seres Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 5, 2024

Revenue(YoY)

64.00K

-93.44%
EPS(YoY)

-0.32

+40.74%

Buy

Mar 31, 2024

Seres Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 250.000K--
--2024/Q1-- / 250.000K--
Mar 5, 20242023/Q464.000K / -180.830K--
--2023/Q3310.000K / 853.000K--
Aug 8, 20232023/Q2126.473M / 125.671M--
May 9, 20232023/Q1-- / 1.582M--
Mar 7, 20232022/Q4975.000K / 6.004M--
Nov 2, 20222022/Q33.444M / 7.010M--
Aug 3, 20222022/Q21.216M / 4.547M--
May 4, 20222022/Q11.493M / 9.519M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 250.000K--
--2024/Q1-- / 250.000K--
Mar 5, 20242023/Q464.000K / -180.830K--
--2023/Q3310.000K / 853.000K--
Aug 8, 20232023/Q2126.473M / 125.671M--
May 9, 20232023/Q1-- / 1.582M--
Mar 7, 20232022/Q4975.000K / 6.004M--
Nov 2, 20222022/Q33.444M / 7.010M--
Aug 3, 20222022/Q21.216M / 4.547M--
May 4, 20222022/Q11.493M / 9.519M--

Unlock Free Earnings Estimates

Seres Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 31, 2024

Buy

  • Buy

    75.00%
  • Hold

    0.00%
  • Sell

    25.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg